During the past decade, Spitalul Clinic Judetean Mures conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 12 clinical trials were completed, i.e. on average, 52.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic Judetean Mures" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Eisai Limited" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic Judetean Mures" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator, "Norgine" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic Judetean Mures" are "Crohn Disease" (3 trials), "Epilepsy" (2 trials), "Major Depressive Disorder" (2 trials), "Multiple Sclerosis" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Spitalul Clinic Judetean Mures" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic Judetean Mures" are "Drug" (35 trials), "Other" (5 trials), "Biological" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ocrelizumab" (3 trials), "Ozanimod" (3 trials), "Infliximab" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic Judetean Mures" are 38 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Spitalul Clinic Judetean Mures". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Spitalul Clinic Judetean Mures, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic Judetean Mures, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Spitalul Clinic Judetean Mures has several departments that took part in Clinical trials: "Spitalul Clinic Judetean de Urgenta Targu-Mures; compartiment Hematologie" - 5 trials, "Spitalul Clinic Judetean de Urgenta Targu Mures, Sectia Clinica Hematologie si Transplant Medular" - 2 trials, "County Clinical Emergency Hospital Targu Mures, II Neurology Department" - 2 trials, "Spitalul Clinic Judetean de Urgenta Targu Mures; Clinica Neurologie" - 2 trials